ISSN 2394-5125
 

Review Article 


ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE

SAMEER SHARMA, SAROJ YADAV, SIBI G*.

Abstract
Gene therapy also called human gene transfer is defined as to cure a particular disease by relocate the genetic material. Lipid nanoparticles serve as the foremost advanced delivery method in consideration of genetic medication. Lipid nanoparticles are currently the advance and remarkable in non-viral delivery process for permissive the analytical potential of genetic medication. Genetic medication supported nucleic acids (RNA and DNA) because they contain uncommon remedial potential as just about any illness are often cured by silencing prophylactic cistron and damaged genes as well as convey a favourable protein. In this review, an attempt was made to clarify the progress in non-viral lipid nanoparticle delivery methods that have enticing properties. Therefore, the therapies supported nucleic acid polymers need refined delivery method to convey these macromolecules to the inside of target cells. Finally, we tend to address current application of lipid nanoparticles science as enforced to genetic medication.

Key words: lipid nanoparticles, non-viral gene delivery, gene therapy, cationic liposomes


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by SAMEER SHARMA
Articles by SAROJ YADAV
Articles by SIBI G*
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

SHARMA S, YADAV S, G S. ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE. JCR. 2020; 7(1): 11-15. doi:10.22159/jcr.07.01.02


Web Style

SHARMA S, YADAV S, G S. ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE. http://www.jcreview.com/?mno=302644968 [Access: September 14, 2020]. doi:10.22159/jcr.07.01.02


AMA (American Medical Association) Style

SHARMA S, YADAV S, G S. ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE. JCR. 2020; 7(1): 11-15. doi:10.22159/jcr.07.01.02



Vancouver/ICMJE Style

SHARMA S, YADAV S, G S. ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE. JCR. (2020), [cited September 14, 2020]; 7(1): 11-15. doi:10.22159/jcr.07.01.02



Harvard Style

SHARMA, S., YADAV, . S. & G, . S. (2020) ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE. JCR, 7 (1), 11-15. doi:10.22159/jcr.07.01.02



Turabian Style

SHARMA, SAMEER, SAROJ YADAV, and SIBI G. 2020. ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE. Journal of Critical Reviews, 7 (1), 11-15. doi:10.22159/jcr.07.01.02



Chicago Style

SHARMA, SAMEER, SAROJ YADAV, and SIBI G. "ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE." Journal of Critical Reviews 7 (2020), 11-15. doi:10.22159/jcr.07.01.02



MLA (The Modern Language Association) Style

SHARMA, SAMEER, SAROJ YADAV, and SIBI G. "ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE." Journal of Critical Reviews 7.1 (2020), 11-15. Print. doi:10.22159/jcr.07.01.02



APA (American Psychological Association) Style

SHARMA, S., YADAV, . S. & G, . S. (2020) ACCREDITING GENE THERAPIES WITH NON-VIRAL LIPID NANOPARTICLES DELIVERY SYSTEM AND ITS RELATED PERTINENCE. Journal of Critical Reviews, 7 (1), 11-15. doi:10.22159/jcr.07.01.02